Studies indicated that the intravesical administration of the TRPV4 antagonist HC067047 to block TRPV4 could ameliorate decreased bladder capacity and increased voiding frequency in both RVS and cyclophosphamide-induced cystitis animals34,36. This evidence concerns the gene TRPV4 and chronic cystitis.